Anticancer activity of RAPTA-EA1 in triple-negative BRCA1 proficient breast cancer cells: single and combined treatment with the PARP inhibitor olaparib

Autor: Hongthong, Khwanjira, Nhukeaw, Tidarat, Temboot, Pornvichai, Dyson, Paul J., Ratanaphan, Adisorn
Zdroj: In Heliyon August 2021 7(8)
Databáze: ScienceDirect